NHS England Biosimilar Medicine Guide

The newly updated guide ‘What is a biosimilar medicine?’ was developed by NHS England, in partnership with BIA and key organisations including MHRA, NICE, ABPI and RPS. This document provides an update for key clinical and non-clinical stakeholders about the role of biosimilar medicines in the NHS in England and to support the safe, effective and consistent use of all biological medicines, including biosimilar medicines, to the benefit of patients, in line with the principles of shared decision-making to ensure individuals are supported to make decisions that are right for them - www.england.nhs.uk/shared-decision-making.